Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGE
4651
Hinge Health
HNGE
$5.73B
| $52.3K | ﹤0.01% |
+1,066
| New | +$55.8K |
|
4652
Lantronix
LTRX
$223M
| $52.3K | ﹤0.01% |
11,435
-5,840
| -34% | -$21.6K |
|
4653
Afya
AFYA
$1.35B
| $52K | ﹤0.01% |
+3,333
| New | +$51.1K |
|
|
MCHPP
4654
Microchip Technology Inc 7.50% Series A Preferred Stock
MCHPP
| $51.9K | ﹤0.01% |
880
-4,547
| -84% | -$285K |
|
4655
BBVA Argentina
BBAR
$3.85B
| $51.3K | ﹤0.01% |
+6,165
| New | +$83.2K |
|
4656
Acumen Pharmaceuticals
ABOS
$152M
| $51.3K | ﹤0.01% |
29,991
| – | – |
|
|
HIVE
4657
HIVE Digital Technologies
HIVE
$679M
| $51.2K | ﹤0.01% |
+12,700
| New | +$34.2K |
|
4658
Caribou Biosciences
CRBU
$146M
| $50.7K | ﹤0.01% |
21,772
+84
| +0.4% | +$159 |
|
4659
Cognyte Software
CGNT
$655M
| $50.5K | ﹤0.01% |
6,017
| – | – |
|
4660
Cellebrite
CLBT
$3.76B
| $50.5K | ﹤0.01% |
2,723
-137,314
| -98% | -$2.16M |
|
4661
Deutsche Bank
DB
$66.6B
| $50.1K | ﹤0.01% |
1,416
+1,358
| +2,341% | +$46.3K |
|
4662
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
| $50.1K | ﹤0.01% |
240
| – | – |
|
4663
Diageo
DEO
$49.6B
| $49.9K | ﹤0.01% |
523
+386
| +282% | +$40.5K |
|
4664
Vera Bradley
VRA
$98.7M
| $49.9K | ﹤0.01% |
24,817
-1,385
| -5% | -$2.94K |
|
|
FHDG
4665
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$68.2M
| $49.8K | ﹤0.01% |
1,510
-4,179
| -73% | -$135K |
|
|
CLYM
4666
Climb Bio
CLYM
$693M
| $49.8K | ﹤0.01% |
24,753
-4,624
| -16% | -$8.59K |
|
4667
Innovative Solutions & Support
ISSC
$319M
| $49.6K | ﹤0.01% |
+3,972
| New | +$55.5K |
|
|
NXXT
4668
NextNRG Inc
NXXT
$41.8M
| $49.5K | ﹤0.01% |
27,054
-5,785
| -18% | -$10.1K |
|
4669
Gerdau
GGB
$9.54B
| $49.4K | ﹤0.01% |
+15,935
| New | +$48.2K |
|
4670
The ONE Group
STKS
$55.9M
| $49.3K | ﹤0.01% |
16,657
| – | – |
|
|
MRDN
4671
Meridian Holdings Inc
MRDN
$139M
| $49.2K | ﹤0.01% |
3,626
+211
| +6% | +$3.46K |
|
4672
Corbus Pharmaceuticals
CRBP
$165M
| $49.1K | ﹤0.01% |
3,884
+3,293
| +557% | +$31.3K |
|
4673
Tilray
TLRY
$543M
| $48.6K | ﹤0.01% |
2,810
-30,091
| -91% | -$288K |
|
4674
Silicom
SILC
$201M
| $48.6K | ﹤0.01% |
2,743
| – | – |
|
4675
Reynolds Consumer Products
REYN
$5.42B
| $47.9K | ﹤0.01% |
1,958
-34,518
| -95% | -$781K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.